Medicine supply
ADHD medication shortages in the US
What the FDA’s drug shortage list says today about ADHD medicines. Trace checks it every day.
FDA data as of November 4, 2026.
| Medicine | Brands include | On the FDA’s list | Forms listed | FDA update |
|---|---|---|---|---|
| Amphetamine | Adderall, Adderall XR, Adzenys XR-ODT, Dyanavel XR, Evekeo | In short supply | Tablet | November 3, 2026 |
| Dextroamphetamine | Dexedrine, ProCentra, Xelstrym, Zenzedi | In short supply | Tablet | November 3, 2026 |
| Lisdexamfetamine | Vyvanse | In short supply | Capsule; Tablet, Chewable | November 3, 2026 |
| Methylphenidate | Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM | In short supply | Film, Extended Release; Tablet | November 3, 2026 |
| Dexmethylphenidate | Azstarys, Focalin, Focalin XR | Not listed | ||
| Atomoxetine | Strattera | Not listed | ||
| Viloxazine | Qelbree | Not listed | ||
| Guanfacine | Intuniv | Not listed | ||
| Clonidine | Kapvay | Not listed |
This is the FDA’s national list. It doesn’t mean your pharmacy is out.
The FDA lists medicines by their generic name. The brands come from Trace’s US medicines list.
See the FDA’s list →Hear about it in Trace
Add your medicine in Trace, and it lets you know when the FDA lists it as in short supply, and when it’s no longer listed. Trace also counts down to your next refill from how many you have.
Coming soonApp StoreGet it onGoogle Play
When you can’t get your medicine
What people can do when a pharmacy is out, from the FDA and others.
Read the article →